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Abstract A two new compounds with potential biologically
active were synthesized: ethyl 4-(2H-4,6-dimethyl-3-oxo-2,3-
dihydroisothiazolo [5,4-b] pyridin-2-yl) butanoate and ethyl
4-(2H-4,6-dimethyl-2,3-dihydroisothiazolo [5,4-b] pyridin-3-
yloxy) butanoate. The structures of all of the newly formed
compounds were identified by elemental analysis, FTIR and
1H NMR. Their optical properties were studied in ethanol and
n-hexane by UV–Vis absorption and fluorescence spectrosco-
py. The ground-state and excited-state properties were inves-
tigated using the density functional theory (DFT) and the
time-dependent density functional theory (TDDFT) methods.
The results showed differences between emission spectra in
ethanol and n-hexane solution (solvatochromism) for both
new compounds.
Keywords Synthesis . Fluorescence . DFT . Excited state
Introduction
The interest in the fluorescent molecules has steadily increas-
ing in recent years. Fluorescent biomarkers and probes pro-
vide in-depth knowledge about biological system. Many sci-
entific articles have focused on the absorption and emission
properties of differently substituted benzoxazoles and
benzothiazoles because of their high quantum yields. They
have a wide range of applications as fluorescent probes and
as intermediates for dyes [1–4]. Although a number of papers
have been published concerning the fluorescent properties of
different heterocyclic systems, isothiazolo [4,5-b] pyridine
moiety has not yet been extensively studied.
Here we report the synthesis and fluorescence properties of
novel derivatives of isotiazolo [5,4-b] pyridine. Early studies
demonstrated that some of isotiazolopyridines containing dif-
ferent substituents have been investigated because of their
biological activity. Their activity depends usually on nature
of substituents attached to the isothiazole ring. For example,
2-(4-substituted-piperazin-1-ylalkyl)-3-oxoisothiazolo [5,4-b]
pyridines display strong analgesic activity [5, 6] and moderate
antimycobacterial properties [7]. Other authors have also
suggested antiagregative action of derivatives of isothiazolo
[5,4-b] pyridine [8].
On the other hand, the literature reports examples of
antinociceptive agents bearing an alkanoic acid or ester moi-
eties linked to the 3-nitrogen of 2-oxo-3H-benzoxazole ring
[9, 10]. Gulcan and co-workers [10] synthesized 4-(5-chloro-
2(3H)-benzoxazolon-3-yl) butanoic acid and its ethyl ester
with analgesic activity that was higher or comparable to that
of aspirin and, what is more, without gastric side effect.
Taking into account the interesting biological activity of
isothiazolopyridines and related benzoxazoles, we have de-
scribed novel ethyl 4-(2H-4,6-dimethyl-3-oxo-2,3-
dihydroisothiazolo [5,4-b] pyridin-2-yl) butanoate and its 3-
O-substituted isomer. The aim of this work is to synthesize
and investigate the basic fluorescence properties of new com-
pounds. The presence of strong basic and electron deficient
pyridine ring in the isothiazolo [4,5-b] pyridine moiety makes
these systems different from the better known benzoxazole
and benzothiazole rings.
E. Krzyżak (*)
Department of Inorganic Chemistry, Wrocław Medical University,
ul. Borowska 211A, 50-556 Wrocław, Poland
e-mail: edward.krzyzak@umed.wroc.pl
M. Śliwińska :W. Malinka
Department of Chemistry of Drugs, WroclawMedical University, ul.
Borowska 211, 50-556 Wrocław, Poland




All reagents and solvents were purchased from commercial
suppliers. Dry solvent was obtained according to the standard
procedure. Flash column chromatographic purifications were
performed using Sigma-Aldrich 60A silica gel 230–400mesh.
Progress of the reaction was monitored by TLC on silica gel
60 F254-coated TLC plates (Fluka Chemie Gmbh) and visu-
alized by UV light at 254 nm.
Methods and Instruments
The proton nuclearmagnetic resonance (1HNMR) spectra were
recorded on a Brucker 300 Mhz NMR spectrometer using
tetramethylsilane (TMS) as internal reference. Chemical shifts
are reported as δ in parts per million (ppm). The samples were
prepared by dissolving 5 mg of each form in 600 μl of CDCl3.
FTIR spectra were run on a Perkin-Elmer Spectrum Two
UATR FT-IR spectrometer. The samples were applied as solids.
Thermal characteristic was carried out on a Mettler Toledo
DCS 25 measuring cell with TC15 TA Controller, calibrated
with indium to ensure the accuracy of the calorimetric scale.
Samples weighing 3 mg were characterized in sealed 40 μL
aluminium pans and subjected to thermal analysis under a
flowing argon atmosphere (30 cm3 min−1), using heating rate
of 5 °C min−1.
Elemental analyses for carbon, nitrogen and hydrogenwere
carried out on an Carlo Erba NA 1500 analyser and were
within±0.4 % of the theoretical value.
Computational Methods
The electronic structure calculations were carried out using
Gaussian 09 program package [11]. The ground state geomet-
ric optimizations was calculated using density functional the-
ory (DFT) with Becke’s three-parameter hybrid exchange
function with the Lee–Yang–Parr gradient corrected
correlation (B3LYP) [12–14] functional in combination with
6–311+G (d, p) basis set. The electronic properties, such as
absorption and emission wavelengths, oscillator strengths,
were calculated using time-dependent density functional the-
ory at the TDDFT/6–311+G (d, p) level. The hybrid func-
tionals PBE0 [15] were employed in calculations.
Results and Discussion
Synthesis
Procedure for the preparation of Ethyl 4-(2H-4,6-dimethyl-3-
oxo-2,3-dihydroisothiazolo [5,4-b] pyridin-2-yl) butanoate
(1) and Ethyl 4-(2H-4,6-dimethyl-2,3-dihydroisothiazolo [5,
4-b] pyridin-3-yloxy) butanoate (2) (Fig. 1).
1 ,08 g (6 mmol ) of 4 ,6 -d imethyl -3 -oxo-2 ,3 -
dihydroisothiazolo [5,4-b] pyridine [16] was dissolved in an
ethanolic solution of sodium ethoxide prepared by the reaction
of Na° (0,14 g, 6 mmol) with 30 mL of anh. ethanol. After
evaporation to dryness under vacuum, the residue was dissolved
in 30 mL N, N-dimethylformamide and then 0,99 g (6,6 mmol)
of ethyl 4-chlorobutanoate was added, heated for 12 h., cooled
to room temperature and poured into 50 mL ice-water. The
precipitate was collected by suction filtration. The residue was
chromatograhed [CC; ethyl acetate:cyclohexene:chloroform
(2:2:1)]. The fractions containing the product of Rf=0,83
afforded 1,06 g of 2 (yield: 60 %), whereas fractions of Rf=0,
55 gave additionally 0,53 g 1 (yield: 30 %).
The final compounds were characterizes by FTIR and 1H
NMR methods. Selected results are given below.
1:Anal.C13H16N2O2S (m.w. 294,39);
1H NMR (CDCl3) δ:
1,25 t (3H, OCH2CH3, J=7,2 Hz), 2,03-2,13 m(2H, CH2CH2-
CH2), 2,40 t(2H, CH2CH2CO, J=7,5 Hz), 2,60 s(3H, CH3), 2,
74 s(3H, CH3), 3,92 t(2H, NCH2, J=7,2), 4,12 q(2H, OCH2-
CH3, J=7,2), 6,94 s(1H, ArH). FT-IR (UATR, selected lines):
1720 (C=O, ester), 1670 (3-C=O) cm-1. Anal. Calcd: C, 57,




























Fig. 1 Scheme for the
preparation of Ethyl 4-(2H-4,6-
dimethyl-3-oxo-2,3-
dihydroisothiazolo [5,4-b]




278 J Fluoresc (2015) 25:277–282
2:Anal.C13H16N2O2S (m.w. 294,39);
1H NMR (CDCl3) δ:
1,25 t (3H, OCH2CH3, J=7,2 Hz), 2,18-2,24 m(2H, CH2CH2-
CH2), 2,52 t(2H, CH2CH2CO, J=7,5 Hz), 2,63 s(3H, CH3), 2,
66 s(3H, CH3), 4,13 q(2H, OCH2CH3, J=7,2), 4,54 t(2H,
OCH2CH2, J=6), 6,93 s(1H, ArH). FT-IR (UATR, selected
lines): 1720 (C=O, ester) cm-1. Anal. Calcd: C, 57,11; H, 6,
17; N, 9,52. Found: C, 57,46; H, 6,15; N, 9,52.
Additionally, the compounds were analyzed by differential
scanning calorimetry. The DSC trace shows only one thermal
effect (Fig. 2). It corresponds to melting process. The melting
temperature was determined as 57 °C for compound 1 and
52 °C for compound 2.
UV–vis Absorption Spectra
The experimental UV–Vis spectra in ethanol and n-hexane for
compound 1, 2 are shown in Figs. 3 and 4 and their spectra
data are summarized in Table 1. The results showed strong
broad absorption bands starting at 365 nm with maximum at
320 (ethanol) and 318 nm (n-hexane) for compound 1 and
345 nm with maximum 305 nm for compound 2. The calcu-
lated absorption maxima values have been found to be 336
(ethanol), 309 nm (n-hexane) for compound 1 and 291 (etha-
nol), 294 nm (n-hexane) for compound 2.
Fluorescence Spectra
The fluorescence spectra was recorded in ethanol and n-
hexane at a concentration of 1.0×10-5 mol dm-1. Their emis-
sion spectra are shown in Figs. 3 and 4 and their spectra data are
summarized in Table 1. The maximal emission peaks of com-
pound 1 are located at 407 nm in n-hexane solution and 430 nm
in ethanol solution. The fluorescence intensity in ethanol solu-
tion is much higher (Fig. 5). The calculated emission maxima
values have been found to be 425 (ethanol), 403 nm (n-hexane)
and they are in good accordance with experimental. For com-
pound 2, the maximal emission peaks are located at 360 nm (n-
hexane) and 380 nm (ethanol). The calculated values are 360
Fig. 2 DSC curves for studied compounds heated at 5 °C min−1
Fig. 3 Normalized UV–Vis (solid line) and emission (dot line) spectra in
ethanol (black) and n-hexane (red) solution for compound 1
Fig. 4 Normalized UV–Vis (solid line) and emission (dot line) spectra in
ethanol (black) and n-hexane (red) solution for compound 2
Table 1 Experimental and calculated spectra in ethanol and n-hexane
solution for Ethyl 4-(2H-4,6-dimethyl-3-oxo-2,3-dihydroisothiazolo
[5,4-b] pyridin-2-yl) butanoate (1) and Ethyl 4-(2H-4,6-dimethyl-2,3-
dihydroisothiazolo [5,4-b] pyridin-3-yloxy) butanoate (2)
Compound UV–Vis spectra λmax(nm) Fluorescence spectra λmax(nm)
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and 362 nm, respectively. The fluorescence intensity in ethanol
solution is much higher, similarly as for compound 1 (Fig. 5).
Fluorescence quantum yields were determined in different
solvents by using anthracene (Φ=0.36 in cyclohexane) as a
reference standard using the comparative method. The fluo-
rescence quantum yields of the synthesized compounds were
0.15 (ethanol) and 0.10 (n-hexane) for 1 and 0.10 (ethanol)
and 0.07 (n-hexane) for 2.
Calculations
Based on our theoretical results the fluorescent state of both
compounds corresponds to the orbital transition from the
highest occupied molecular orbital (HOMO) to the lowest
unoccupied molecular orbital (LUMO). The atomic orbital
compositions of the frontier molecular orbital are sketched
in Fig. 6. In the HOMO, the charge density is mainly accu-
mulated on the pyridine ring. In case of the LUMO, more
charge density moves to the isothiazole part. The transitions
which are observed are assigned as π→π*. As shown in
Figs. 2 and 3, the value of maximum absorption peaks for
Fig. 5 Experimental emission spectra in ethanol (black) and n-hexane
(red) solution for compound 1 (solid line) and compound 2 (dot line)
Fig. 6 The plots of HOMO and
LUMO orbital contour for
molecule 1 and 2
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the first band is almost identical in both solutions and different
for N-isomer and O-isomer. For both isomers, the fluores-
cence spectra was found to be dependent on solvent polarity
and intensity in ethanol solution is much higher than n-hexane
(Fig. 5). As is well known with increasing solvent polarity, the
ground state molecule is better stabilized by solvation than the
molecule in the excited state (blue shift will result), or better
stabilization of the molecule in the first excited state relative to
the ground state, with increasing solvent polarity, will lead to
positive solvatochromism (red shift). An important parameter
is the dipole moment difference between the ground and ex-
cited state. The dipole moment calculated within TDDFT for-
malism for the N-isomer (compound 1) in the ground state is
found as 2.05D in the n-hexane solution, and increases to 2.88
D in excite state. In the ethanol solution, the dipole moment is
slightly higher and increases from 3.26 D (ground state) to
4.25 D (excite state). For the O-isomer (compound 2) the
dipole moments are slightly higher: in the ground state 3.27
D and excite state 4.08 D (n-hexane solution) and 5.80 D, 6.92
D, respectively in ethanol solution. The difference between
the ground and excited state is rather small in all cases: Δμ=
0.83, 0.99, 0.81 and 1.12 D, respectively. Those calculations
are in good agreement with experimental absorption spectra.
However, the emission spectra in ethanol solution is red
shifted. Avariety of environmental factors affect fluorescence
emission, including interactions between the molecule and
surrounding solvent. Solvent molecules assist in stabilizing
and further lowering the energy level of the excited state by
re-orienting around the excited fluorophore and in the results
reducing the energy separation between the ground and excit-
ed states. Increasing the solvent polarity (ethanol) reduces the
solvent effect on the excited state energy level. Our calculation
also does not include the intermolecular interactions. More-
over, both isomers have atoms with free electron pairs (O and
N). Therefore the transitions can have mixed character: n→
π* and π→π*, and affect the emission spectra and solvent
effect.
Conclusion
In this work, two new ester derivatives of isothiazolo [4, 5-b]
pyridine, compounds with potential biologically active, were
synthesized. Their structures were confirmed by FTIR, 1H
NMR, elemental analysis techniques. The absorption and
emission spectra of titled compounds in ethanol and n-
hexane solution were studied experimentally and theoretically.
The results showed that the fluorescence spectra depends on
solution. The emission spectra in ethanol solution is red
shifted. The calculated dipole moment increases in excited
state and is higher in ethanol than n-hexane solution. Polarity
of the solvent also affects the intensity of the emission band.
The results obtained clearly show differences in optical prop-
erties of N- and O-isomer. Due to light emission properties
and ease methods of synthesis, the new derivatives may be
considered for the development of functional dyes.
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